drugset / Trial / NCT03469089

Touchscreen-based Cognitive Tests in Healthy Volunteers

NCT03469089

Phase 1 Unknown 16 enrolled University of Eastern Finland
RandomizedCrossoverDouble-blindBasic science

Summary

This phase Ib study aims to evaluate applicability of touchscreen-based cognitive test battery for assessment of ketamine-induced schizophrenia-like cognitive deficits in healthy volunteers. Additionally, the study aims to assess whether ketamine-induced cognitive deficits are reversed by modafinil using touchscreen-based test battery for testing of cognition.

Timeline

Start
2018-03-12
Primary completion
2018-05-16
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.31 mg/kg
Subject Ketamine Small molecule 0.58 mg/kg
Subject Modafinil Small molecule 100 mg

Indications